Alignment Healthcare (NASDAQ: ALHC) president offloads 30,000 shares

Rhea-AI Filing Summary

Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock. The shares were sold at a weighted-average price of $20.8733 per share under a pre-arranged Rule 10b5-1 trading plan.

After this transaction, Maroney directly holds 1,028,813 shares of Alignment Healthcare common stock. The sale was executed in multiple trades at prices ranging from $20.76 to $21.07 per share.

Insider Trade Summary 10b5-1

Net Seller: 30,000 shares ($626,199)

Net Sell 1 txn

Insider Maroney Dawn Christine

Role President

Sold 30,000 shs ($626K)

Type	Security	Shares	Price	Value
Sale	Common Stock	30,000	$20.8733	$626K

Holdings After Transaction: Common Stock — 1,028,813 shares (Direct)

Footnotes (1)

1. Date of Rule 10b5-1 plan adoption: 05/22/2025 The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.76 to $21.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Key Figures

Shares sold: 30,000 shares Weighted-average sale price: $20.8733 per share Price range of trades: $20.76–$21.07 per share +3 more

6 metrics

Shares sold 30,000 shares Open-market sale of common stock on April 15, 2026

Weighted-average sale price $20.8733 per share Reported sale price in Form 4 column 4

Price range of trades $20.76–$21.07 per share Multiple transactions within this range

Shares owned after transaction 1,028,813 shares Direct holdings following the reported sale

Net share change 30,000 shares sold Net-sell direction per transaction summary

Rule 10b5-1 plan adoption date 05/22/2025 Footnote identifying trading plan adoption date

Key Terms

Rule 10b5-1 plan, weighted-average price, open-market sale, Form 4

4 terms

Rule 10b5-1 plan regulatory

"Date of Rule 10b5-1 plan adoption: 05/22/2025"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted-average price financial

"The reported price in column 4 is a weighted-average price."

open-market sale financial

"transaction_action: open-market sale of common stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4): reporting this transaction"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2026		S(1)		30,000	D	$20.8733(2)	1,028,813	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Date of Rule 10b5-1 plan adoption: 05/22/2025

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.76 to $21.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alignment Healthcare (ALHC) report on this Form 4?

Alignment Healthcare president Dawn Christine Maroney reported selling 30,000 shares of common stock in an open-market transaction. The sale was executed at a weighted-average price of $20.8733 per share across multiple trades within a disclosed price range.

At what prices did Dawn Christine Maroney sell ALHC shares?

The reported 30,000 Alignment Healthcare shares were sold at a weighted-average price of $20.8733. Individual trades occurred within a per-share price range from $20.76 to $21.07, as disclosed in the Form 4 filing footnote.

How many Alignment Healthcare (ALHC) shares does Dawn Christine Maroney hold after the sale?

Following the 30,000-share sale, Dawn Christine Maroney directly holds 1,028,813 shares of Alignment Healthcare common stock. This post-transaction ownership figure is explicitly stated in the Form 4 as the total shares beneficially owned after the reported transaction.

Was the ALHC insider sale made under a Rule 10b5-1 trading plan?

Yes. The Form 4 states that the transaction was made pursuant to a Rule 10b5-1 trading plan adopted on 05/22/2025. Such plans pre-arrange trades, providing structure and reducing the significance of short-term market timing decisions.

Who is the insider involved in the latest ALHC Form 4 transaction?

The insider is Dawn Christine Maroney, identified as the president of Alignment Healthcare, Inc. She filed a Form 4 reporting an open-market sale of 30,000 shares of the company’s common stock, with details on pricing and remaining holdings.